Cargando…
Circulating epigenetic biomarkers for detection of recurrent colorectal cancer
BACKGROUND: The sensitive detection of recurrent colorectal cancer (CRC) by the measurement of circulating tumor DNA (ctDNA) might improve the chance of a cure. This study compared a quantitative methylated ctDNA test with carcinoembryonic antigen (CEA) in the setting of surveillance for recurrence....
Autores principales: | Symonds, Erin L., Pedersen, Susanne K., Murray, David, Byrne, Susan E., Roy, Amitesh, Karapetis, Christos, Hollington, Paul, Rabbitt, Philippa, Jones, Frederick S., LaPointe, Lawrence, Segelov, Eva, Young, Graeme P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155014/ https://www.ncbi.nlm.nih.gov/pubmed/31909823 http://dx.doi.org/10.1002/cncr.32695 |
Ejemplares similares
-
A cross‐sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor‐derived DNA with CEA for detection of recurrent colorectal cancer
por: Young, Graeme P., et al.
Publicado: (2016) -
Detection of methylated
BCAT1
and
IKZF1
after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence
por: Pedersen, Susanne K., et al.
Publicado: (2022) -
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
por: Reece, Mifanwy, et al.
Publicado: (2019) -
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018) -
Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
por: Symonds, Erin L., et al.
Publicado: (2018)